Trial Profile
Efficacy study of Liraglutide as add on therapy against cardiovascular risk in type 2 diabetic patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2018
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Insulin; Metformin
- Indications Cardiovascular disorders; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 Feb 2018 New trial record
- 01 Feb 2018 Results published in the Diabetes Therapy